GlassScriptPhysician profile
Jennifer E Foster
NPI 1083368641
$3,606.52
in general payments reported to CMS, 2019-2025
18 companies · $1,534 in 2025
The $1,534 reported for 2025 was more than what 91% of Nurse Practitioner providers received nationally (typical 2025 total: $174).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2022: $781 · 2023: $630 · 2024: $662 · 2025: $1,534.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,825.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,825.43 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novo Nordisk INC | $1,184.59 | 2022-2025 | Ozempic, Rybelsus |
| Boehringer Ingelheim Pharmaceuticals, INC. | $445.92 | 2023-2025 | Jardiance |
| Insulet Corporation | $275.27 | 2022-2025 | Omnipod |
| Corcept Therapeutics | $247.68 | 2024-2025 | Korlym |
| Lilly USA, LLC | $243.84 | 2022-2025 | Mounjaro, Zepbound, Trulicity |
| Dexcom, INC. | $237.38 | 2022-2025 | Dexcom G6 Transmitter |
| Astrazeneca Pharmaceuticals LP | $193.04 | 2022-2025 | Wainua |
| Beta Bionics, INC. | $175.28 | 2023-2025 | Ilet Bionic Pancreas, Ilet Insulin Infusion Kit Contact Detach, Ilet Insulin Infusion Kit Inset |
| Sequel Med Tech, LLC | $159.69 | 2025 | Twiist |
| Horizon Therapeutics Plc | $121.33 | 2023 | Tepezza |
| Tandem Diabetes Care, INC. | $118.99 | 2025 | T:Slim X2 Insulin Pump With Control-Iq |
| Medtronic, INC. | $66.40 | 2022-2025 | Minimed 780g |
| Sanofi-Aventis U.S. LLC | $44.93 | 2024 | |
| Xeris Pharmaceuticals, INC. | $27.64 | 2023-2025 | Gvoke Hypopen, Recorlev |
| Ascensia Diabetes Care US INC. | $18.11 | 2024 |
Show all 18 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Amgen INC. | $17.11 | 2024 | Tepezza |
| Radius Health, INC. | $15.50 | 2023 | Tymlos |
| Cequr Corporation | $13.82 | 2024 | Cequr Simplicity |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jennifer Foster listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.